Trexquant Investment LP Arcus Biosciences, Inc. Transaction History

Trexquant Investment LP

$7.59 Billion
Q3 2024

A detailed history of Trexquant Investment LP transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 87,996 shares of RCUS stock, worth $1.36 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

87,996

Previous 252,586 65.16%

Holding current value

$1.36 Million

Previous $3.85 Million 65.03%

% of portfolio

0.02%

Previous 0.06%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$13.69 - $18.01 $2.25 Million - $2.96 Million	-164,590 Reduced 65.16%	87,996 $1.35 Million
Q2 2024 Aug 13, 2024	BUY	$14.59 - $18.48 $3.13 Million - $3.96 Million	214,469 Added 562.66%	252,586 $3.85 Million
Q1 2024 May 14, 2024	SELL	$14.83 - $20.18 $80,378 - $109,375	-5,420 Reduced 12.45%	38,117 $719,000
Q4 2023 Feb 09, 2024	SELL	$13.43 - $19.63 $471,393 - $689,013	-35,100 Reduced 44.64%	43,537 $831,000
Q3 2023 Nov 13, 2023	BUY	$17.62 - $23.54 $1.39 Million - $1.85 Million	78,637 New	78,637 $1.41 Million
Q1 2023 May 15, 2023	SELL	$15.96 - $23.15 $99,654 - $144,548	-6,244 Reduced 24.91%	18,827 $343,000
Q4 2022 Feb 13, 2023	BUY	$19.7 - $35.71 $493,898 - $895,285	25,071 New	25,071 $518,000
Q2 2022 Aug 11, 2022	BUY	$17.23 - $37.73 $141,113 - $309,008	8,190 New	8,190 $208,000
Q2 2021 Aug 12, 2021	SELL	$22.75 - $35.77 $163,549 - $257,150	-7,189 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$26.16 - $41.39 $163,133 - $258,108	-6,236 Reduced 46.45%	7,189 $202,000
Q4 2020 Feb 11, 2021	SELL	$17.0 - $32.36 $667,267 - $1.27 Million	-39,251 Reduced 74.51%	13,425 $349,000
Q3 2020 Nov 06, 2020	BUY	$17.14 - $25.47 $399,824 - $594,138	23,327 Added 79.48%	52,676 $903,000
Q2 2020 Aug 07, 2020	BUY	$13.97 - $36.56 $42,468 - $111,142	3,040 Added 11.55%	29,349 $726,000
Q1 2020 May 08, 2020	BUY	$8.78 - $19.28 $230,993 - $507,237	26,309 New	26,309 $365,000
Q2 2019 Aug 09, 2019	SELL	$7.29 - $13.38 $119,271 - $218,910	-16,361 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$8.95 - $12.49 $146,430 - $204,348	16,361 New	16,361 $204,000

Others Institutions Holding RCUS

# of Institutions

200

Shares Held

51.5M

Call Options Held

236K

Put Options Held

141K

View Full List

About Arcus Biosciences, Inc.

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.12B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

More about RCUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account

Trexquant Investment LP Arcus Biosciences, Inc. Transaction History